Potential Properties of Legumes as Important Functional Foods for Management of Type 2 Diabetes: A Short Review
International Journal of Nutrition and Food Sciences
Volume 4, Issue 2-1, March 2015, Pages: 6-9
Received: Sep. 13, 2014;
Accepted: Sep. 17, 2014;
Published: Sep. 20, 2014
Views 3317 Downloads 448
Zahra Bahadoran, Nutrition and Endocrine Research Center, and Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Parvin Mirmiran, Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran
The concept of functional foods in health promotion and disease management has been developed during the past two decades. Beyond the basic nutritional functions, functional foods have several potential biological properties and have hence been given much attention. Leguminous seeds (peas, beans, lentils, peanuts), rich sources of bioactive proteins and peptides, functional fiber, indigestible carbohydrates and phytochemicals, have been recently introduced them as unique functional foods. Studies showed that higher consumption of legumes could attenuate postprandial glycemia and insulinemia, increase insulin sensitivity, regulate lipid and lipoprotein metabolism, and diminish oxidative stress. The potential efficacies of leguminous seeds and their bioactive components have made them as excellent choice for supplementary treatment in type 2 diabetes.
Potential Properties of Legumes as Important Functional Foods for Management of Type 2 Diabetes: A Short Review, International Journal of Nutrition and Food Sciences. Special Issue: Functional Foods and Nutraceuticals for Management of Type 2 Diabetes.
Vol. 4, No. 2-1,
2015, pp. 6-9.
Santaguida PL, Balion C, Hunt D. Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. Evid Rep Technol Assess 2008; 12: 1–11.
Gadi R, Samaha FF. Dyslipidemia in type 2 diabetes mellitus. Curr Diab Rep 2007; 7(3):228-34.
Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002; 23:599-622.
Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, Ristow M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003; 52:812-7.
Constantino MI, Molyneaux L, Limacher-Gisler F, Al-Saeed A, Luo C, Wu T, et al. Long-Term Complications and Mortality in Young-Onset Diabetes: Type 2 diabetes is more hazardous and lethal than type 1 diabetes. Diabetes Care 2013.
Lloyd A, Sawyer W, Hopkinson P. Impact of long-term complications on quality of life in patients with type 2 diabetes not using insulin. Value Health 2001; 4: 392-400.
Bahadoran Z, Mirmiran P, Azizi F. Potential efficacy of broccoli sprouts as a unique supplement for management of type 2 diabetes and its complications. J Med Food 2013; 16(5):375-82.
Mirmiran P, Bahadoran Z, Azizi F. Functional foods-based diet as a novel dietary approach for management of type 2 diabetes and its complications: A review. World J Diabetes 2014; 5(3):267-81.
Madar Z, Stark AH. New legume sources as therapeutic agents. Br J Nutr 2002; 88 Suppl 3:S287-92.
Tovar J. Bioavailability of carbohydrates in legumes: digestible and indigestible fractions. Arch Latinoam Nutr 1996; 44(4 Suppl 1):36S-40S.
Guillon F, Champ MM. Carbohydrate fractions of legumes: uses in human nutrition and potential for health. Br J Nutr 2002; 88 Suppl 3:S293-306.
Duranti M. Grain legume proteins and nutraceutical properties. Fitoterapia 2006; 77: 67-82.
Venn BJ, Mann JI. Cereal grains, legumes and diabetes. Eur J Clin Nutr 2004; 58(11):1443-61.
Jenkins DJ, Kendall CW, Augustin LS, Mitchell S, Sahye-Pudaruth S, Blanco Mejia S, et al. Effect of legumes as part of a low glycemic index diet on glycemic control and cardiovascular risk factors in type 2 diabetes mellitus: a randomized controlled trial. Arch Intern Med 2012; 172(21):1653-60.
López-Amorós ML, Hernández T, Estrella I. Effect of germination on legume phenolic compounds and their antioxidant activity. J Food Comp Anal 2006; 19: 277-283.
Higgins JA. Whole Grains, Legumes, and the Subsequent Meal Effect: Implications for Blood Glucose Control and the Role of Fermentation. J of Nutr Metabol 2012; 2012: 829238.
Zou Y, Chang SK, Gu Y, Qian SY. Antioxidant activity and phenolic compositions of lentil (Lens culinaris var. Morton) extract and its fractions. J Agric Food Chem 2011; 59(6):2268-76.
Boualga A, Prost J, Taleb-Senouci D, Krouf D, Kharoubi O, Lamri-Senhadji M, et al. Purified chickpea or lentil proteins impair VLDL metabolism and lipoprotein lipase activity in epididymal fat, but not in muscle, compared to casein, in growing rats. Eur J Nutr 2009; 48:162-9.
Faris M, Takruri H, Issa A. Role of lentils (Lens culinaris L.) in human healthand nutrition: a review. Mediterr J Nutr Metab 2012.
Sahms H, Tahbaz F, Entezari M, Abadi A. effect of cooked lentil on glycemic control and blood lipids in type 2 diabetic patients. Arya Atheros 2008; 4(1): 1-5.
Yao F, Sun C, Chang SK. Lentil polyphenol extract prevents angiotensin II-induced hypertension, vascular remodelling and perivascular fibrosis. Food Funct 2012; 3(2):127-33.
Yao Y, Cheng XZ, Wang LX, Wang SH, Ren G. Major Phenolic Compounds, Antioxidant Capacity and Antidiabetic Potential of Rice Bean (Vigna umbellata L.) in China. Int J Mol Sci. 2012; 13(3):2707-16.
Helmstädter A. Beans and diabetes: Phaseolus vulgaris preparations as antihyperglycemic agents. J Med Food 2010; 13: 251-4.
Geil PB, Anderson JW. Nutrition and health implications of dry beans: a review. J Am Coll Nutr 1994; 13: 549-58.
Preuss HG. Bean amylase inhibitor and other carbohydrate absorption blockers: effects on diabesity and general health. J Am Coll Nutr 2009; 28: 266-76.
Thompson SV, Winham DM, Hutchins AM. Bean and rice meals reduce postprandial glycemic response in adults with type 2 diabetes: a cross-over study. Nutr J 2012; 11:23.
Anderson JW, Bush HM. Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies. J Am Coll Nutr 2011; 30:79-91.
Azadbakht L, Shakerhosseini R, Atabak S, Jamshidian M, Mehrabi Y, Esmaill-Zadeh A. Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy. Eur J Clin Nutr 2003; 57:1292-4.
Bhathena SJ, Velasquez MT. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 2002; 76: 1191-201.
Gilbert ER, Liu D. Anti-diabetic functions of soy isoflavone genistein: mechanisms underlying its effects on pancreatic β-cell function. Food Funct 2013; 4: 200-12.
Ronis MJ, Chen Y, Badeaux J, Badger TM. Dietary soy protein isolate attenuates metabolic syndrome in rats via effects on PPAR, LXR, and SREBP signaling. J Nutr 2009; 139:1431-8.
Yang B, Chen Y, Xu T, Yu Y, Huang T, Hu X, Li D. Systematic review and meta-analysis of soy products consumption in patients with type 2 diabetes mellitus. Asia Pac J Clin Nutr 2011; 20(4):593-602.
Borradaile NM, de Dreu LE, Wilcox LJ, Edwards JY, Huff MW. Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms. Biochem J 2002; 366:531-9.
Potter SM. Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr 1995; 125: 606S-611S.
Liu CF, Pan TM. Beneficial Effects of Bioactive Peptides Derived from Soybean on Human Health and Their Production by Genetic Engineering, Soybean and Health. Soybean and health (2011). Hany El-Shemy (Ed.)
Frigolet ME, Torres N, Uribe-Figueroa L, Rangel C, Jimenez-Sanchez G, Tovar AR. White adipose tissue genome wide-expression profiling and adipocyte metabolic functions after soy protein consumption in rats. J Nutr Biochem 2011; 22: 118-29.
Cheik NC, Rossi EA, Guerra RL, Tenório NM, Oller do Nascimento CM, Viana FP, et al. Effects of a ferment soy product on the adipocyte area reduction and dyslipidemia control in hypercholesterolemic adult male rats. Lipids Health Dis 2008; 7:50.
Zhang Z, Lanza E, Ross AC, Albert PS, Colburn NH, Rovine MJ, et al. A high-legume low-glycemic index diet reduces fasting plasma leptin in middle-aged insulin-resistant and -sensitive men. Eur J Clin Nutr 2011; 65(3):415-8.
Segura R, Javierre C, Lizarraga MA. Other relevant components of nuts: phytosterols, folate and minerals. Br J Nutr 2006; 96: S36–S44.